Literature DB >> 3141191

Glucuronyl transferase deficiency and mild hereditary spherocytosis: effect of splenectomy.

S W Eber1, D Ullrich, C P Speer, R Armbrust, W Schröter.   

Abstract

In a 6-year-old girl an association of hereditary spherocytosis and a defect in hepatic bilirubin metabolism has been found. The patient suffered from mild compensated haemolytic anaemia and excessive hyperbilirubinaemia (maximum concentration 581 mumol/l), the serum activity of liver enzymes was slightly increased. Examination of the erythrocyte membrane proteins revealed a deficiency of the major membrane skeletal protein, spectrin (about 75% of normal) which is probably the basic genetic defect of hereditary spherocytosis. Examination of the patient's family revealed a recessive mode of inheritance. The concentration of bilirubin conjugates in the patient's serum was decreased due to a reduced UDP-glucuronyl transferase activity found in homogenates of liver tissue. Histological liver examination showed an intrahepatic cholestasis, which is a secondary and reversible alteration resulting from severe hyperbilirubinaemia. After splenectomy, normalization of the increased haemolysis and hepatic dysfunction was observed. The excessive hyperbilirubinaemia can be explained by the association of an increased bilirubin load due to haemolytic anaemia and the diminished hepatic conjugation of bilirubin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141191     DOI: 10.1007/bf00442481

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  Autohemolysis and other changes resulting from the incubation in vitro of red cells from patients with congenital hemolytic anemia.

Authors:  J G SELWYN; J V DACIE
Journal:  Blood       Date:  1954-05       Impact factor: 22.113

2.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  Phenobarbitone of jaundice in haemolytic patients.

Authors:  G Perona; R Corrocher; M Frezza; G C Falezza; R Cellerino; C Tiribelli; A Fusaro; G De Sandre
Journal:  Br J Haematol       Date:  1973-12       Impact factor: 6.998

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  The molecular organization of the red cell membrane skeleton.

Authors:  C M Cohen
Journal:  Semin Hematol       Date:  1983-07       Impact factor: 3.851

6.  A case of elliptocytosis associated with a truncated spectrin chain.

Authors:  V Ohanian; J P Evans; W B Gratzer
Journal:  Br J Haematol       Date:  1985-09       Impact factor: 6.998

7.  Marked reduction of spectrinin hereditary spherocytosis in the common house mouse.

Authors:  A C Greenquist; S B Shohet; S E Bernstein
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

8.  Analysis of bilirubin and bilirubin mono- and di-conjugates. Determination of their relative amounts in biological samples.

Authors:  N Blanckaert
Journal:  Biochem J       Date:  1980-01-01       Impact factor: 3.857

9.  Partial deficiency of erythrocyte spectrin in hereditary spherocytosis.

Authors:  P Agre; J F Casella; W H Zinkham; C McMillan; V Bennett
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

10.  Glucuronidation of bilirubin and the occurrence of pigment gallstones in patients with chronic haemolytic diseases.

Authors:  J Fevery; R Verwilghen; T G Tan; J De Groote
Journal:  Eur J Clin Invest       Date:  1980-06       Impact factor: 4.686

View more
  1 in total

1.  Triosephosphate isomerase deficiency: haemolytic anaemia, myopathy with altered mitochondria and mental retardation due to a new variant with accelerated enzyme catabolism and diminished specific activity.

Authors:  S W Eber; A Pekrun; A Bardosi; M Gahr; W K Krietsch; J Krüger; R Matthei; W Schröter
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.